Periodic reassessment prevents overtreatment; if enlargement normalizes or plates near closure

https://jeffreyuqeh969.cloudhinter.com/posts/human-growth-hormone-fda-approved-uses-what-applies-to-children

Periodic reassessment prevents overtreatment; if growth normalizes or plates close closure, clinicians taper or stop therapies to avert unnecessary possibility.